FDA Recall: FLUVIRIN
FDA recall of influenza virus vaccine, FLUVIRIN

Novartis Vaccines and Diagnostics, Inc. is recalling FLUVIRIN (Influenza Virus Vaccine) 2010-2011 Formula Multidose Vials, lot # 111812P1.
This recall of the above lot has been initiated because, for a small number of vials, cracked vial necks leading to broken vials have been detected. In addition, cracks in the vial necks carry the potential risk of product sterility being compromised, however Novartis Vaccines is not aware of any related safety issues being reported. For patients who have received vaccine from this affected lot within the past week, clinical assessment may be considered in accordance with routine medical judgment. Patients previously vaccinated with a dose from this lot who did not experience problems should be unaffected, and therefore no action, such as further clinical assessment or revaccination, is required.
Only FLUVIRIN multidose vials with the above specified lot number are subject to this recall; all other FLUVIRIN multidose vials and all FLUVIRIN prefilled syringes are unaffected and safe to use.
Consignees are asked to immediately check their inventory of FLUVIRIN multidose vials; refrain from using this product and return any vials from this lot obtain replacement product free of charge.
All information on this site is provided “as-is” for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health.
More health news
Prescription DrugsBeacon Hill Pharmacy d/b/a Rxtra Solutions Issues Voluntary Nationwide Recall of Certain Sterile Products
Recall issued due to question of sterility assurance
FDA AlertsFDA Alerts Healthcare Providers and Patients of Nationwide Recall by Specialty Pharmacy
Clinical Specialties Compounding Pharmacy recalls all lots of sterile products
Accusure Insulin Syringes Recalled
Accusure Insulin Syringes Recalled